ADVERTISEMENT
Press release content from PR Newswire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from PR Newswire
Press release content from PR Newswire. The AP news staff was not involved in its creation.

Essent Biologics Launches Human Mesenchymal Stem Cells For Regenerative Medicine, Biopharmaceutical And Cell Therapy Research

June 8, 2021 GMT
Essent Biologics Launches Human Mesenchymal Stem Cells For Regenerative Medicine, Biopharmaceutical And Cell Therapy Research
1 of 2
Essent Biologics Launches Human Mesenchymal Stem Cells For Regenerative Medicine, Biopharmaceutical And Cell Therapy Research
1 of 2
Essent Biologics Launches Human Mesenchymal Stem Cells For Regenerative Medicine, Biopharmaceutical And Cell Therapy Research

CENTENNIAL, Colo., June 8, 2021 /PRNewswire/ -- Essent Biologics™, a nonprofit biotechnology company setting a new standard in human-derived biomaterials and comprehensive data for research, today announced the launch of its human mesenchymal stem cells (hMSCs) for regenerative medicine, biopharmaceutical and cell therapy research. Essent Biologics will provide highly-characterized, low-passaged hMSCs. Each vial will contain over one million cells at thaw and have a passage level of P0 or P1 to ensure potency.

The company’s hMSCs are the first commercial hMSC product that is recovered, expanded and cryopreserved without the use of antibiotics or animal products. Additionally, with each order of hMSCs, Essent Biologics can provide full donor information coupled with a source biopsy called the Essent Origin Sample.

ADVERTISEMENT

“This is an import milestone in getting our products into the hands of brilliant researchers,” said Corey Stone, Executive Director, Essent Biologics. “Our stem cells are the ideal input to your experiment, whether you are developing cell-based therapies, spheroids, bioprinted constructs, microfluidic chips or complex in vitro models.”

As a strategic venture from AlloSource, a nonprofit leader in providing allografts that maximize tissue donation to help surgeons heal their patients, Essent Biologics’ hMSCs are produced under current Good Manufacturing Practices (cGMP). The company builds their hMSCs to align with International Society for Cell & Gene Therapy (ISCT) guidelines to ensure identity, function and sterility.

For additional information on the company’s product pipeline, please visit essentbiologics.org/products/.

ADVERTISEMENT

About Essent Biologics
Essent Biologics is setting a new standard in human-derived biomaterials and comprehensive data for research. The nonprofit biotechnology company provides low-passaged primary cells, research tissue and scaffold materials to advance regenerative medicine research from benchtop to bedside. Essent Biologics supplies products in small or large volumes and serves as a manufacturing partner by creating master cell banks and an inventory of custom products within a tailored specification. In order to ensure reliable product quality, safety and efficacy, all Essent Biologics products are developed using robust design control processes and produced under current Good Manufacturing Practices (cGMP). For more information, please visit essentbiologics.org.

View original content to download multimedia: http://www.prnewswire.com/news-releases/essent-biologics-launches-human-mesenchymal-stem-cells-for-regenerative-medicine-biopharmaceutical-and-cell-therapy-research-301308295.html

SOURCE Essent Biologics